A Phase I Trial of A-CAR032 in Participants With mCRPC

Clinical trial NCT07344311 · RECRUITING

Trial details

NCT number: NCT07344311
Sponsor: Shanghai AbelZeta Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Castration-Resistant Prostate Cancer

Start date: 2026-01-13
Primary completion: 2027-01-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.